ASA Adjudication on Health & Beauty Innovations Ltd

A website for NicoBloc said that the product could help with nicotine addiction by blocking up to 99% of nicotine and tar. The Advertising Standards Authority (ASA) found that the ads violated the country’s Advertising Code because they claimed that the product could be used to treat nicotine addiction without being a licensed medical device. The ASA also concluded that the tests used to determine the product’s ability to block nicotine and tar were not sufficient to support the ad’s claims and the ads were therefore misleading. The ASA ordered the company not to use the ads again in their current form and required the company to provide robust documentary evidence to support smoking cessations claims in the future. 

DOWNLOAD DOCUMENT

ASA Adjudication on Health & Beauty Innovations Ltd, Complaint Ref: A14-266848 (2014).

  • United Kingdom
  • Oct 29, 2014
  • Advertising Standards Authority

Parties

Plaintiff Unidentified complainants

Defendant Health & Beauty Innovations Ltd

Legislation Cited

Committee of Advertising Practice (CAP Code), Edition 12, Rule 3.7 (Substantiation)

Committee of Advertising Practice (CAP Code), Edition 12, Rules 12.1 and 12.11 (Medicines, medical devices, health related products and beauty products)

Committee of Advertising Practice (CAP) Code, Rule 3.1 (Misleading Advertising)

Related Documents

Type of Litigation

Tobacco Control Topics

Substantive Issues

Type of Tobacco Product

None